Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glecaprevir/Pibrentasvir for the Treatment of PTSD

NCT05446857 is registered in ClinicalTrials.gov with White River Junction Veterans Affairs Medical Center as lead sponsor.

NCT NCT05446857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glecaprevir/Pibrentasvir for the Treatment of PTSD
Lead sponsor
White River Junction Veterans Affairs Medical Center
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2023
Completion date
April 15, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd